Influence of local and systemic factors of type 2 diabetes mellitus on the functional status of platelets in patients with diabetic retinopathy and maculopathy
Journal Title: Офтальмологический журнал - Year 2018, Vol 0, Issue 6
Abstract
Background: To date, there is no information on relationships of systemic (activation of the sympathoadrenal and renin- angiotensin systems, SAS and RAS, respectively) and local (inflammation and remodeling of the retinal extracellular matrix and activation of the ocular purinergic system) mechanisms of the development of diabetic maculopathy (DMP) and diabetic macular edema (DME). Purpose: To identify the influence of systemic and local factors of type 2 diabetes mellitus (DM) on functional status of platelets in DMP and DME under conditions of severe nonproliferative (NPDR) or proliferative diabetic retinopathy (PDR). Materials and Methods: This study included 42 type 2 DM patients (42 eyes), of which 31 patients (31 eyes) and 11 patients (11 eyes) were found to have DMP in the presence of PDR and severe NPDR, respectively. Platelet aggregation in vitro to ADP, adrenaline, angiotensin 2 (Ang2), platelet activation factor (PAF) and collagen were assessed spectrophotometrically with a Chrono-Log aggregometer. Results: As platelet hyperreactivity to AN II, adrenalin, PAF and collagen were found in all study patients, activation of the RAS and SAS, and inflammation and remodeling of retinal extracellular matrix are non-specific pathogenetic mechanisms of DMP. Platelet reactivity to ADP was higher in PDR than in severe NPDR (р=0.008), which reflected the features of the pathogenesis of PDR. Development of DME in patients with DMP could be caused by a pronounced dysregulation of purinergic signaling in the eye, activation of the RAS and inflammation, which was reflected by platelet hyperreactivity to ADP, AN II and PAF, whereas a high platelet reactivity to collagen was characteristic of the absence of DME. Conclusion: The analysis of functional status of platelets allowed elucidating platelet activation mechanisms and identifying major platelet agonists that enabled platelet involvement in progression of DMP and development of DME in type 2 DM patients with proliferative diabetic retinopathy.
Authors and Affiliations
S. Mogilevskyy, Yu. Panchenko, D. Ziablitsev
Keywords
Related Articles
- EP ID EP432241
- DOI 10.31288/oftalmolzh201862329
- Views 52
- Downloads 0
The method of four-point fixation of the intraocular lens in the absence of capsular support (preliminary study)
Introduction. Fixation of an intraocular lens (IOL) in the absence of capsular support is still a challenge for ophthalmic surgeons. Purpose. To develop a technique of four-point IOL fixation in the absence of capsular...
Typology of macular edema associated with retinal vein occlusion: variety of pathomorphological picture of the eye fundus. Part I
Background. Conservative treatment of macular edema associated with retinal vein occlusion is often unable to control progression of the disease. ME chronization is observed in ≈30% patients, excludes spontaneous resolut...
Metabolic correction of experimental diabetic retinopathy
Introduction. Diabetic retinopathy (DR) is diagnosed in 50% of the total number of patients suffering from type 1 diabetes mellitus with diabetes duration of over 10 years and in 75-90% of patients with diabetes duration...
Serum adiponectin levels in obese type 2 diabetic patients with diabetic retinopathy
Background. Diabetic retinopathy (DR) is one of the main complications of diabetes mellitus, the main cause of irreversible blindness in patients of working age in industrialized countries, has a high incidence rates and...
On the scientific results of the 3rd Global Pediatric Ophthalmology Congress (London 2018) and on the effectiveness of publishing articles in high-ranked ophthalmology journals
In this day and age of information technology and significantly accelerated scientific and technical progress in all fields of knowledge including ophthalmology, it is crucial for scientific results obtained to be publis...